Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2001
09/18/2001US6291206 BMP receptor proteins
09/18/2001US6291205 Generating preferentially bonded recombinant proteins; transform cell, express expression vector in cells and recover genetically engineered protein
09/18/2001US6291204 Culturing genetically engineered cell containing farnesyl pyrophosphate and isopentyl pyrophosphate to express zeaxanthin; dna sequences encode geranylgeranyl pyrophosphate synthase and other enzymes from flavobacterium
09/18/2001US6291199 Human phosphodiesterase type IVC, and its production and use
09/18/2001US6291195 Generating ligands which bind preferential human receptors; incubate cells expressing preferential binding protein with modulator, detect adjustment in binding activity
09/18/2001US6291194 Assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound
09/18/2001US6291192 Method for identifying conditions that facilitate recombinant protein folding
09/18/2001US6291191 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization
09/18/2001US6291188 Metallic solid supports modified with nucleic acids
09/18/2001US6291187 Detecting target dna by selective amplification of linear sequences or rolling circle amplification while improving sensitivity by using additional stages or platforms and poly-primer mixtures for exponential amplification
09/18/2001US6291186 Method for screening for unknown organisms
09/18/2001US6291185 Electrochemical denaturation of double-stranded nucleic acid
09/18/2001US6291184 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
09/18/2001US6291182 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
09/18/2001US6291179 Product and method for separation of a sample containing multiple sources of genetic material using a solid medium
09/18/2001US6291176 Identification of a DNA region potentially useful for the detection of mycobacterium kansasii
09/18/2001US6291175 Methods for treating a neurological disease by determining BCHE genotype
09/18/2001US6291170 Complementary deoxyribonucleic acid is synthesized by rna using a complementary primer linked to a rna polymerase promoter, anti-sense rna is transcribed from the cdna when rna polymerase binds the promoter region; diagnosis/forensic
09/18/2001US6291167 Method for determining the existence of a mutation
09/18/2001US6291166 Irreversibly capturing rna or dna using highly electropositive solid phases matrices, as a means for aqueous washes, buffer changes and volume reduction during procedure; for direct analysis of single or double stranded nucleic acid
09/18/2001US6291165 Shuffling of heterologous DNA sequences
09/18/2001US6291162 Determining amount of lactamase activity; transfecting cells with a nucleic acid having an expression control sequence linked to a secretion defective sequence; mixing cells with lactamase substrate; determine amount of cleaved substrate
09/18/2001US6291156 Plant pest control
09/18/2001US6290972 Provides isolated human and murine cd40-l polypeptides that bind to the extracellular binding region of a cd40 receptor.
09/18/2001US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis
09/18/2001US6290965 DNA encoding human papillomavirus type 6A
09/18/2001US6290962 Urease-based vaccine and treatment for helicobacter infection
09/18/2001US6290960 Vaccine and antitoxin for the treatment of C. difficile disease
09/18/2001US6290957 Anti-IgE antibodies and method of improving polypeptides
09/18/2001US6290954 Contacting a source suspected of containing native prpsc with a diagnostically effective amount of an antibody characterized by its ability to bind to native prpsc in situ; and determining whether the antibody binds to any material
09/18/2001US6290953 May be a conjugate which includes a targeting portion adapted to target the conjugate to a specific cell type or anatomical location.
09/18/2001US6290952 Method of dephosphorylating an endotoxin in vivo with alkaline phosphatase
09/18/2001US6290949 Used to treat restenosis, especially when incident to injury by angioplasty.
09/18/2001CA2238879C Thereapeutic applications for the anti-t-bam (cd40-l) monoclonal antibody 5c8
09/18/2001CA2145182C Dna encoding human alpha 1 adrenergic receptors and uses thereof
09/18/2001CA2100116C Virus resistant plants
09/18/2001CA2079802C Walk-through mutagenesis
09/18/2001CA2036197C Modified hil-6
09/18/2001CA2023894C Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins
09/18/2001CA1341293C Alpha-subunit of the mac-1 leukocyte adhesion receptor
09/18/2001CA1341292C The manufacture and expression of consensus human leukocyte interferon
09/15/2001WO2001068859A2 Il-17 receptor like molecules and uses thereof
09/15/2001WO2001066747A2 Proteins named fctrx and nucleic acids encoding same
09/15/2001CA2403370A1 Il-17 receptor like molecules and uses thereof
09/15/2001CA2401552A1 Proteins named fctrx and nucleic acids encoding same
09/13/2001WO2001067129A2 Epoxide polymer surfaces
09/13/2001WO2001067110A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor
09/13/2001WO2001067107A1 Modulation of histone deacetylase
09/13/2001WO2001067105A1 Carriers coated with polysaccharides, their preparation and use
09/13/2001WO2001067103A1 Function homology screening
09/13/2001WO2001066803A2 Phytomics: a genomic-based approach to herbal compositions
09/13/2001WO2001066802A1 SYSTEMS AND METHODS TO QUANTIFY AND AMPLIFY BOTH SIGNALING AND PROBES FOR cDNA CHIPS AND GENES EXPRESSION MICROARRAYS
09/13/2001WO2001066801A2 Very low density lipoprotein receptor polymorphisms and uses therefor
09/13/2001WO2001066799A2 Real time quantitative pcr with intercalating dye for single and multiplex target dna
09/13/2001WO2001066798A2 Random truncation and amplification of nucleic acid
09/13/2001WO2001066795A1 Method for analysing the length of a nucleic acid molecule
09/13/2001WO2001066794A1 Molecular methods for detecting guar gum additions to locust bean gum
09/13/2001WO2001066785A1 Phosphatidyl serine receptors and uses thereof
09/13/2001WO2001066784A1 Inhibitor of differentiation knockout mammals and methods of use thereof
09/13/2001WO2001066782A1 Adeno-associated viral compositions and methods
09/13/2001WO2001066781A1 Conditional immortalisation of cells
09/13/2001WO2001066780A2 Homologous recombination-mediated transgene alterations in plants
09/13/2001WO2001066779A2 Arabitol or ribitol as positive selectable markers
09/13/2001WO2001066778A2 Production of foreign polypeptides in plants as viral coat protein fusions
09/13/2001WO2001066777A1 Transgenic trees exhibiting increased growth, biomass production and xylem fibre length, and methods for their production
09/13/2001WO2001066776A2 Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products
09/13/2001WO2001066775A2 Dna joining method
09/13/2001WO2001066774A1 A system to control the expression of a given gene using another gene that encodes a polypeptide with recombinant activity
09/13/2001WO2001066773A2 Nucleic acids that code for oxidosqualene cyclases
09/13/2001WO2001066772A2 Heparinase iii and uses thereof
09/13/2001WO2001066771A2 Human serine protease
09/13/2001WO2001066770A1 Novel polypeptide--- a human signal peptidase 15 and polynucleotide encoding it
09/13/2001WO2001066769A1 Novel polypeptide--- a human yiplp28 and polynucleotide encoding it
09/13/2001WO2001066768A1 Dna molecule coding for a polygalacturonase of strawberry and the uses thereof
09/13/2001WO2001066767A2 Direct production of desacetylcephalosporin c
09/13/2001WO2001066766A2 A matrix metalloproteinase (mmp-25) expressed in skin cell
09/13/2001WO2001066765A2 26583, a serine/threonine phosphatase and uses thereof
09/13/2001WO2001066764A2 16835, a human phospholipase c and uses thereof
09/13/2001WO2001066763A2 23436, a human ubiquitin protease family member and uses thereof
09/13/2001WO2001066762A1 Human extracellular signal regulated kinases
09/13/2001WO2001066761A1 Inorganic pyrophosphatases from lepidopters
09/13/2001WO2001066760A2 Novel human kinase interacting protein and polynucleotides encoding the same
09/13/2001WO2001066759A2 26886, a novel carnitine acyltransferase family member and uses therefor
09/13/2001WO2001066758A2 25934, a novel fatty acid desaturase and uses therefor
09/13/2001WO2001066757A2 25934, a novel fatty acid desaturase and uses therefor
09/13/2001WO2001066756A2 22105, a human thioredoxin family member and uses thereof
09/13/2001WO2001066755A2 Monocotyledonous plant genes and uses thereof
09/13/2001WO2001066754A1 Human antibodies against eotaxin and their use
09/13/2001WO2001066753A2 Human genes and gene expression products
09/13/2001WO2001066752A2 Reproduction-specific genes
09/13/2001WO2001066751A2 G protein-coupled receptors
09/13/2001WO2001066750A2 G protein-coupled receptors
09/13/2001WO2001066749A2 A member of the lectin superfamily
09/13/2001WO2001066748A2 Full length expressed human polynucleotides and the polypeptides they encode
09/13/2001WO2001066746A2 G-protein coupled receptor related polypeptides
09/13/2001WO2001066745A2 Presenilin/crk binding polypeptides (pcbp) and methods of use thereof
09/13/2001WO2001066744A2 Human transporter proteins and polynucleotides encoding the same
09/13/2001WO2001066743A2 A potassium channel molecule and uses therefor
09/13/2001WO2001066742A2 G-protein coupled receptors
09/13/2001WO2001066741A2 Kcnb: a novel potassium channel protein